Merck & Co., Inc.
MRK
$79.29
$1.171.50%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 17.43B | 17.12B | 12.15B | 13.74B | 2.31B |
| Total Depreciation and Amortization | 4.38B | 4.25B | 4.03B | 3.87B | 3.68B |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.06B | 3.77B | 3.75B | 1.16B | 11.47B |
| Change in Net Operating Assets | -4.00B | -3.67B | -1.67B | -2.07B | -2.70B |
| Cash from Operations | 20.88B | 21.47B | 18.26B | 16.69B | 14.76B |
| Capital Expenditure | -3.84B | -3.37B | -3.42B | -3.54B | -3.72B |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -3.35B | -4.09B | -4.09B | -746.00M | -11.45B |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -659.00M | -269.00M | 1.28B | 1.56B | 2.07B |
| Cash from Investing | -7.85B | -7.73B | -6.24B | -2.73B | -13.10B |
| Total Debt Issued | 3.60B | 3.60B | 3.60B | 1.66B | 5.94B |
| Total Debt Repaid | -3.04B | -1.29B | -754.00M | -755.00M | -2.51B |
| Issuance of Common Stock | 109.00M | 177.00M | 171.00M | 173.00M | 182.00M |
| Repurchase of Common Stock | -2.35B | -1.31B | -1.21B | -1.23B | -1.32B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -7.94B | -7.84B | -7.74B | -7.64B | -7.54B |
| Other Financing Activities | -354.00M | -372.00M | -333.00M | -311.00M | -325.00M |
| Cash from Financing | -9.97B | -7.03B | -6.27B | -8.11B | -5.57B |
| Foreign Exchange rate Adjustments | 1.00M | -293.00M | 260.00M | -191.00M | -202.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.06B | 6.41B | 6.02B | 5.66B | -4.12B |